Bayer Aktiengesellschaft (ETR:BAYN)
44.46
+0.05 (0.11%)
Oct 16, 2026, 5:38 PM CET
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 87,830 employees as of June 30, 2026. The number of employees decreased by 1,726 or -1.93% compared to the same quarter last year. That makes Bayer Aktiengesellschaft the 364th largest employer in the world and 19th in Germany.
Employees
87,830
Change
-1,726
Growth
-1.93%
Revenue / Employee
€516,623
Profits / Employee
€19,788
Market Cap
43.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 87,830 | -1,726 | -1.93% |
| Mar 31, 2026 | 87,757 | -3,128 | -3.44% |
| Dec 31, 2025 | 87,280 | -4,584 | -4.99% |
| Sep 30, 2025 | 88,502 | -5,743 | -6.09% |
| Jun 30, 2025 | 89,556 | -7,011 | -7.26% |
| Mar 31, 2025 | 90,885 | -7,304 | -7.44% |
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Sep 30, 2024 | 94,245 | -6,628 | -6.57% |
| Jun 30, 2024 | 96,567 | -5,481 | -5.37% |
| Mar 31, 2024 | 98,189 | -3,546 | -3.49% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Sep 30, 2023 | 100,873 | -1,423 | -1.39% |
| Jun 30, 2023 | 102,048 | 134 | 0.13% |
| Mar 31, 2023 | 101,735 | 982 | 0.97% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Sep 30, 2022 | 102,296 | 2,482 | 2.49% |
| Jun 30, 2022 | 101,914 | 2,475 | 2.49% |
| Mar 31, 2022 | 100,753 | 1,424 | 1.43% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 178,486 |
| Fresenius Medical Care AG | 107,226 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| Fielmann Group AG | 18,928 |
| Drägerwerk AG & Co. KGaA | 16,009 |
| Sartorius Aktiengesellschaft | 14,279 |
| Ottobock SE & Co. KGaA | 9,406 |
Bayer Aktiengesellschaft News
- 3 days ago - Bayer (BAYN) -- Agricultural and Pharmaceutical Growth | Ruffer Total Return International Q3 2026 - GuruFocus
- 9 days ago - Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting - Business Wire
- 9 days ago - Bayer partners with actress Melissa Joan Hart to increase awareness of Lynkuet - TheFly
- 9 days ago - Actress and Menopause Advocate Melissa Joan Hart Partners with Bayer to Raise Awareness about Lynkuet® (elinzanetant), a Prescription Treatment for Moderate to Severe Hot Flashes due to Menopause - Business Wire
- 9 days ago - Actress and Menopause Advocate Melissa Joan Hart Partners with Bayer to Raise Awareness about Lynkuet (elinzanetant), a Prescription Treatment for Moderate to Severe Hot Flashes due to Menopause - Wallstreet:Online
- 9 days ago - Bayer announces FDA acceptance of Kerendia sNDA - TheFly
- 9 days ago - Bayer Moves To Expand KERENDIA Into Chronic Kidney Disease Without Diabetes - Nasdaq
- 9 days ago - FDA Accepts Bayer's Filing To Expand KERENDIA Use In CKD Without Diabetes - Nasdaq